Hemophilia - 95 Studies Found
Completed |
: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B : Hemophilia B : 2006-08-14 :
|
Active, not recruiting |
: Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B : Hemophilia B : 2015-11-23 : Genetic: AAVrh10FIX non-replicating recombinant AAVrh10 encoding human FIX (hFIX) |
Recruiting |
: Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B : Hemophilia B : 2016-11-21 |
Active, not recruiting |
: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B : Hemophilia B : 2011-01-06 : Drug: Recombinant factor IX Product, IB1001 On-Demand or Prophylaxis |
Completed |
: Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B : Hemophilia B : 2017-03-16 : Drug: BeneFIX BeneFIX is a recombinant FIX that contains nonacog alfa, reconstituted in solvent and admi |
Active, not recruiting |
: Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B : Hemophilia B : 2012-08-27 : Biological: AskBio009 Single dose IV injection Other |
Completed |
: Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B : Hemophilia B : 2007-06-07 : Drug: BeneFIX (coagulation factor IX (recombinant)) BeneFIX will be administered according to physician' |
Recruiting |
: Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B : Hemophilia B : 2009-09-16 :
|
Completed |
: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) : Hemophilia B : 2005-08-30 : Drug: human coagulation Factor IX Other Name: Nonafact |
Terminated |
: Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B : Hemophilia B : 2004-01-26 : Genetic: Adeno-Associated Viral with Human Factor IX |